Showing results (741-750 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
The Lancet. Oncology|August 18, 2018
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trialMartin J van den Bent, Martin Klein, Marion Smits, et al.
The Lancet. Oncology|June 22, 2014
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trialSusan J Dutton, David R Ferry, Jane M Blazeby, et al.
The Lancet. Oncology|August 28, 2012
Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort studyFlorent de Vathaire, Chiraz El-Fayech, Faten Fedhila Ben Ayed, et al.
The Lancet. Oncology|October 23, 2012
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
The Lancet. Oncology|October 23, 2012
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism studyIsabelle Ray-Coquard, Jean-Yves Blay, Antoine Italiano, et al.
The Lancet. Oncology|March 22, 2015
Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 studyAkira Kawai, Nobuhito Araki, Hideshi Sugiura, et al.
The Lancet. Oncology|August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket studyMilind Javle, Mitesh J Borad, Nilofer S Azad, et al.
The Lancet. Oncology|August 2, 2021
Elective nodal radiotherapy in prostate cancerGert De Meerleer, Charlien Berghen, Alberto Briganti, et al.
The Lancet. Oncology|August 2, 2021
Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancerNan Zhang, Aik Seng Ng, Shijie Cai, et al.
Pageof 336